MENOGON Trademark

Trademark Overview

On Wednesday, September 11, 1996, a trademark application was filed for MENOGON with the United States Patent and Trademark Office. The USPTO has given the MENOGON trademark a serial number of 75164249. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 18, 2011. This trademark is owned by Ferring B.V.. The MENOGON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation used for the stimulation of ovarian follicular growth and spermatogenesis

General Information

Serial Number75164249
Word MarkMENOGON
Filing DateWednesday, September 11, 1996
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 18, 2011
Registration Number2873026
Registration DateTuesday, August 17, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 25, 2004

Trademark Statements

Goods and Servicespharmaceutical preparation used for the stimulation of ovarian follicular growth and spermatogenesis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 18, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address2130 KC Hoofddorp
NL
Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address2130 KC Hoofddorp
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address2130 KC Hoofddorp
NL

Trademark Events

Event DateEvent Description
Friday, March 18, 2011CANCELLED SEC. 8 (6-YR)
Tuesday, August 17, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, May 25, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2004NOTICE OF PUBLICATION
Thursday, March 11, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 26, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 10, 2004CASE FILE IN TICRS
Monday, January 26, 2004PAPER RECEIVED
Friday, July 25, 2003NON-FINAL ACTION MAILED
Wednesday, July 16, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, June 23, 2003ASSIGNED TO EXAMINER
Saturday, June 14, 2003Sec. 1(B) CLAIM DELETED
Saturday, March 1, 2003NOTICE OF ALLOWANCE CANCELLED
Monday, April 28, 2003PETITION TO DIRECTOR - GRANTED
Tuesday, August 13, 2002PETITION TO DIRECTOR RECEIVED
Monday, December 23, 2002PAPER RECEIVED
Wednesday, August 21, 2002EXTENSION 5 GRANTED
Wednesday, August 21, 2002EXTENSION 5 FILED
Monday, August 26, 2002PAPER RECEIVED
Tuesday, August 13, 2002PAPER RECEIVED
Tuesday, March 26, 2002EXTENSION 4 GRANTED
Thursday, February 28, 2002EXTENSION 4 FILED
Wednesday, August 29, 2001EXTENSION 3 GRANTED
Wednesday, August 29, 2001EXTENSION 3 FILED
Monday, April 16, 2001EXTENSION 2 GRANTED
Wednesday, February 28, 2001EXTENSION 2 FILED
Friday, October 13, 2000EXTENSION 1 GRANTED
Monday, August 14, 2000EXTENSION 1 FILED
Tuesday, February 29, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 1999PUBLISHED FOR OPPOSITION
Friday, November 5, 1999NOTICE OF PUBLICATION
Wednesday, August 25, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 19, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 1999NON-FINAL ACTION MAILED
Wednesday, December 16, 1998CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 1998INQUIRY AS TO SUSPENSION MAILED
Tuesday, April 28, 1998LETTER OF SUSPENSION MAILED
Wednesday, September 17, 1997INQUIRY AS TO SUSPENSION MAILED
Friday, March 14, 1997LETTER OF SUSPENSION MAILED
Thursday, March 13, 1997ASSIGNED TO EXAMINER

Related Keywords

menogon follicular growth spermatogenesis ovarian stimulation preparation used pharmaceutical